SYS-CON MEDIA Authors: Mat Mathews, Newswire, David Smith, Tim Crawford, Kevin Benedict

News Feed Item

Clearette Electronic Cigarette Company Makes Charitable Donation to the National Breast Cancer Foundation. Join the Cause

GREAT RIVER, N.Y., Feb. 17, 2014 /PRNewswire/ -- New cancer cases will affect over 1.6 million people in 2014 with more than 200,000 of them attributed to breast cancer.  Breast cancer ranks second in cancer deaths after lung cancer, causing approximately 40,000 deaths per year.  While a variety of factors are known to cause breast cancer, recent research indicates that long-term heavy smoking increases risk as well.

Clearette Electronic Cigarette pledges to continue its involvement in the race against breast cancer and will continue to promote the good fight to encourage all to become more involved financially. 

Clearette Electronic Cigarette Company continues to be strong advocates of stopping smoking and urges others to follow suit. Senior Vice-President Daniel Gambino, whose father recently passed from lung cancer, states "too many of our family members and loved ones that have already died from smoking and related illnesses, it's time for us to join together with the best of our ability to stop these unnecessary deaths. First and foremost, our mission as a company is to help guide our loved ones off of smoking in any manner that is less harmful than the known killer tobacco." 

We strongly urge all who read this release to do what you can donation wise and help fight the good fight with us (Breast Cancer Donations).

Clearette Electronic Cigarettes offers a realistic alternative to smoking tobacco products. Clearette E-cigarette's create a tar and carcinogen-free vapor, which provides the taste and feel of a traditional cigarette without the harmful tobacco smoke, smell, or ash. For more information, please visit


SOURCE Clearette Electronic Cigarette Company

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.